Global Health News and Research

RSS

New funding supports research on new and improved drug treatments for tuberculosis, malaria

University of Toronto and McGill University scientists are leading an international partnership to discover new and improved drug treatments for tuberculosis, malaria and neglected tropical diseases -- thanks to a contribution from Merck Canada Inc., as well as an additional $5 million supplement to a grant from the Bill & Melinda Gates Foundation.

17 Dec 2015

Oxford research programmes to explore link between metabolism, inflammation in metabolic diseases

Two innovative Oxford research programmes will explore the relationship between metabolism and inflammation in metabolic diseases. Obesity, insulin resistance, type 2 diabetes (T2D) and associated cardiovascular disease (CVD) -- all metabolic diseases -- are an epidemic global health problem.

17 Dec 2015

Researchers report development of rapid, low-cost test for detecting TB in resource-limited areas

Tuberculosis (TB) is a highly infectious disease and a major global health problem, especially in countries with developing health care systems. Because there is no fast, easy way to detect TB, the deadly infection can spread quickly through communities. Now, a team reports in ACS Sensors the development of a rapid, sensitive and low-cost method for detecting the disease in resource-limited areas.

17 Dec 2015

Global Health Impact Index can measure actual impact of drugs worldwide

Billions of dollars have been spent on developing drugs and supplying them around the world, but which companies' drugs are actually making an impact? The Global Health Impact Index, headed by Binghamton University Associate Professor Nicole Hassoun and highlighted in a new article published Friday in PLOS ONE, addresses this issue by ranking pharmaceutical companies based on their drugs' impact on global health.

15 Dec 2015

Post-progression afatinib exposure boosts NSCLC outcomes

Continued exposure to afatinib plus paclitaxel can benefit non-small-cell lung cancer patients who developed resistance to erlotinib or gefitinib and progressed after initially responding to afatinib monotherapy, suggest phase III trial results.

11 Dec 2015

Innovative solutions to combat dementia event

Pauline Latham MP OBE hosted the University of Derby at the Houses of Parliament last week, for an event highlighting innovative approaches to cope with the rise of dementia.

From University of Derby Online Learning 10 Dec 2015

WHO launches new comprehensive analysis of global health trends

The World Health Organization (WHO) today launched a new comprehensive analysis of global health trends since 2000 and an assessment of the challenges for the next 15 years.

10 Dec 2015

Adverse environmental changes present potential health hazards to eyes

Another reason to worry about climate change: Expanding areas of arid land, air pollution, and greater exposure to ultraviolet (UV) radiation all present potential health hazards to your eyes, according to Sheila West, Ph.D., vice chair for research at the Wilmer Eye Institute, Johns Hopkins University.

9 Dec 2015

Innovative compound with anti-MRSA qualities may help develop new class of antibiotics

With global health services increasingly worried about the rise of antibiotic resistant diseases, researchers at Maynooth University have discovered a compound whose anti-MRSA qualities pave the way for the development of a new class of antibiotics.

1 Dec 2015

WHO recommends new strategies to treat HIV patients, reduce new infections

The world is poised to end the AIDS epidemic by 2030 – provided it can accelerate the pace of progress achieved globally over the past 15 years, according to a new World Health Organization (WHO) report.

1 Dec 2015

Experts share 10 steps to prevent future disease outbreaks

An independent group of 19 experts from around the globe, convened by the Harvard Global Health Institute and the London School of Hygiene & Tropical Medicine, has issued a hard-hitting analysis of the global response to the 2014-15 Ebola outbreak in West Africa, published in The Lancet.

23 Nov 2015

Georgetown health law experts propose fundamental reform for International Health Regulations

A trio of global health law experts from Georgetown warn the window for fundamental reform of the International Health Regulations -- opened by the Ebola epidemic -- is 'rapidly closing.'

23 Nov 2015

New Series urges renewed focus to combat antimicrobial resistance, highlights lack of access to antimicrobial drugs

The global fight against antimicrobial resistance could be under threat unless the evidence base for policies to control resistance is radically improved, according to a major new Series, published in The Lancet.

20 Nov 2015

Pedestrian wheelchair users more likely to be killed in road traffic collisions than non-wheelchair users

An investigation into how often wheelchair users are killed in car-pedestrian crashes finds they are a third more likely to die than non-wheelchair users; more than half of those deaths occur at intersections.

20 Nov 2015

NIH-led collaboration details research strategy to address brain disorders

Infants are starved of oxygen during difficult births. Children's cognitive function is permanently damaged due to malnutrition or exposure to infections or toxins. Adults suffer from crippling depression or dementia. The breadth and complexity of these and other brain and nervous system disorders make them some of the most difficult conditions to diagnose and treat, especially in the developing world, where there are few resources.

19 Nov 2015

Clinical study shows new Ebola vaccine stimulates strong immune responses in adults

A clinical trial of a new Ebola vaccine (ChAd3-EBO-Z) that resulted from an unprecedented global consortium assembled at the behest of the World Health Organization has found that it is well tolerated and stimulates strong immune responses in adults in Mali, West Africa and in the US, according to a study published in the latest issue of the journal Lancet Infectious Disease.

19 Nov 2015

Rice University study examines variation between blood drops drawn from single fingerprick

When it comes to needles and drawing blood, most patients agree that bigger is not better. But in the first study of its kind, Rice University bioengineers have found results from a single drop of blood are highly variable, and as many as six to nine drops must be combined to achieve consistent results.

18 Nov 2015

Global Health News and Research

New funding supports research on new and improved drug treatments for tuberculosis, malaria

Oxford research programmes to explore link between metabolism, inflammation in metabolic diseases

Researchers report development of rapid, low-cost test for detecting TB in resource-limited areas

Global Health Impact Index can measure actual impact of drugs worldwide

Post-progression afatinib exposure boosts NSCLC outcomes

Innovative solutions to combat dementia event

WHO launches new comprehensive analysis of global health trends

Adverse environmental changes present potential health hazards to eyes

Innovative compound with anti-MRSA qualities may help develop new class of antibiotics

WHO recommends new strategies to treat HIV patients, reduce new infections

Experts share 10 steps to prevent future disease outbreaks

Georgetown health law experts propose fundamental reform for International Health Regulations

New Series urges renewed focus to combat antimicrobial resistance, highlights lack of access to antimicrobial drugs

Pedestrian wheelchair users more likely to be killed in road traffic collisions than non-wheelchair users

NIH-led collaboration details research strategy to address brain disorders

Clinical study shows new Ebola vaccine stimulates strong immune responses in adults

Rice University study examines variation between blood drops drawn from single fingerprick

People confused about antibiotic resistance, shows WHO survey

Negative impact of high-fat diet on red blood cells may promote development of cardiovascular disease

New US bipartisan study advocates promoting global health to advance wide range of American interests

Designing fluidic architecture for scalable diagnostic platforms

Evaluating new approaches for rare disease genomics

Expanding access to NMR with the Fourier 80 Duo

Latest News